Research study Program year 2022 Source: CMS Open Payments

HLBT 2001

Research payments

$190,521

52 payments

Through program year 2022, $190,521 in research payments was reported against HLBT 2001, across 52 payments, paid by Taro Pharmaceuticals USA, Inc..

Paid by: Taro Pharmaceuticals USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2022	Research	$190,521	52

Breakdown

Who paid Research payments · program year 2022

Taro Pharmaceuticals USA, Inc. $190,521 52 payments

Who received the money Research payments · program year 2022

Newco 3A Research LLC Organisation paid for research $45,350 11 payments
Fxm Clinical Research Miami Llc Organisation paid for research $30,905 5 payments
FXM Clinical Research Ft. Lauderdale LLC Organisation paid for research $29,555 4 payments
Dfw Clinical Research Organisation paid for research $25,265 6 payments
South Florida Research Center Organisation paid for research $19,420 5 payments
Delricht LLC Dba Delricht Research Organisation paid for research $17,396 10 payments
Peak Research Organisation paid for research $14,165 5 payments
Dermatology Consulting Services Organisation paid for research $6,060 3 payments
Moore Clinical Research Inc. Organisation paid for research $2,405 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.